This research demonstrates body weight changes in EMT6 models during SHP2 inhibitor therapy, suggesting enhanced efficacy of RTK/RAS/MAPK and PD-1 therapies.
Supplementary Figure S7. Body weight change of EMT6 syngeneic model during the treatment. Mean ± SEM was shown.
No takes yet. Share an insight, caveat, or question.
Kang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: